Tutorials
InMed Pharmaceuticals Inc logo

InMed Pharmaceuticals Inc

C$ 4.19 (-1.64%) May 7
P/E:
At Loss
P/B:
0.54
Market Cap:
C$ 33.73M ($ 26.08M)
Enterprise V:
C$ 27.24M ($ 21.06M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap C$:
33.73M
Market Cap $:
26.08M
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value C$:
27.24M
Enterprise Value $:
21.06M
PB Ratio:
0.54
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

InMed Pharmaceuticals Inc
NAICS : 325411 SIC : 3741
815 West Hastings Street, Suite 310, Vancouver, BC, CAN, V6C 1B4
Description
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
Name Current Vs Industry Vs History
Cash-To-Debt 6.44
Equity-to-Asset 0.7
Debt-to-Equity 0.09
Debt-to-EBITDA -0.07
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.44
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -50.51
12-1 Month Momentum % -44.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.13
Quick Ratio 1.78
Cash Ratio 1.45
Days Inventory 1564.56
Days Sales Outstanding 27.68
Days Payable 1613.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.9

Financials (Next Earnings Date:2022-08-16 Est.)

TSX:IN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0.732
EPS (TTM) (C$) 0
Beta 0
Volatility % 93.69
14-Day RSI 0
14-Day ATR (C$) 0
20-Day SMA (C$) 0
12-1 Month Momentum % -44.44
52-Week Range (C$) 3.35 - 13.695013
Shares Outstanding (Mil) 8.05

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

InMed Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data